Welcome to the 7th International Cancer Cluster Showcase!
Cutting edge oncology innovations from leading North American and European industry clusters will be presented in compact 4 min presentations giving you the opportunity to learn about the latest innovations from about 20+ companies.
11:30 – 12:30 p.m. REGISTRATION AND LIGHT LUNCH with POSTER SESSION
12:30 – 12:45 p.m. Opening and Welcome by ICCS: Organizing Partners and Sponsors Welcome Notes by Allison Hilton, Senior Advisor, Healthcare Corporate Banking, DNB Healthcare and by Pat Devitt – President of Precision Oncology
12:45 – 1:15 p.m. Company pitches I: Immunovaccine (IMV) Inv. Alligator Bioscience Avvinity Therapeutics Third Coast Therapeutics OncoImmunity Leuko Labs Inc. 1:15 – 1:25 p.m. Boehringer Ingelheim Presentation, Scott DeWire, Global Head of BD&L Cancer Immunology, Immune Modulation and Biotherapeutics
1:25 – 1:50 p.m. Company Pitches II: Amal Therapeutics TYG Oncology Ultimovacs Context Therapeutics IPD Discovery Pharma MIMS
1:50 – 2:15 p.m. NETWORKING BREAK & POSTER SESSION
2:15 – 2:20 p.m. Takeda Oncology Presentation, Paul E. Juniewicz, Senior Director, Oncology Search & Evaluation, Center for External Innovation
2:20 – 2:50 p.m. Company Pitches III: Bessor Pharma Eritech MBF Therapeutics Immune Biosolutions Simplicity Bio FIMMIC
2:50 – 3:00 p.m. Angel Group – Oncology Focus (details tbc)
3:00 – 3:30 p.m. Company Pitches IV: ABIVAX F-Star ASCIL Biopharm Phi Pharma CytoSavvy Final company to be announced
3:30 – 3:35 p.m. Closing Remarks
3:35 – 4:30 p.m. NETWORKING RECEPTION & POSTER SESSION
Participants can find the detailed company profiles on the event website.
Partners from Oslo, Massachusetts, Philadelphia, Quebec, UK Golden Triangle, Catalonia, and the Paris Region are teaming up again to present their oncology pipelines as a satellite event to BIO 2018.
Oslo Cancer Cluster is one of the program supporters.